Both in Biotechnology
TScan Therapeutics vs BioCardia
Over the past year TCRX returned −81.3% and BCDA returned −31.3%; their daily moves had a correlation of 0.18.
TCRX −81.3% BCDA −31.3%Growth of $1, one year, split-adjusted
| Metric | TCRX | BCDA |
|---|---|---|
| Price | $0.2100 | $0.9131 |
| Market cap | $14.2M | $13.8M |
| Today | +11.11% | −0.92% |
| 1 month | −23.7% | −13.9% |
| 6 months | −83.2% | −17.7% |
| Year to date | −79.0% | −27.0% |
| 1 year | −83.1% | −34.3% |
| Revenue growth (YoY) | −65.8% | — |
| Gross margin | 100.0% | — |
| Net margin | −2888.6% | — |
| P/E (TTM) | — | — |
| Price / sales | 2.0× | — |
| Net cash | $67.4M | $4.1M |
| Dividend yield | — | — |
| Volatility (60d) | 143.0% | 68.9% |
| Short % of float | 4.1% | 6.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).